INBS Stock Analysis: Buy, Sell, or Hold?
INBS - Intelligent Bio Solutions Inc. Common Stock
$4.01
-0.10 (-2.43%)
▼
5d:
+69.92%
30d:
+48.52%
90d:
-20.12%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When INBS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
8 traders called INBS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: INBS is 24.1% above its trading range ($3.23). Market expects -7.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: INBS is 24.1% above its trading range ($3.23). Market expects -7.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.11
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.42
9.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INBS is currently trading at $4.01, which is considered extended relative to its 30-day fair value range of $2.23 to $3.23. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.5) compared to its historical average (14.5). Remarkably, the market is currently pricing in an annual earnings decline of 7.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, INBS is in a strong downtrend. Immediate support is located at $2.27, while resistance sits at $5.20.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+199.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INBS is in a strong downtrend. Immediate support is located at $2.27, while resistance sits at $5.20.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+199.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.23 -
$3.23
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
41.4%
All Signals
- BEARISH: Price significantly overextended (+24.1% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 199.3% below Wall St target ($12.00)
Trading Range Analysis
30-Day Trading Range
$2.23 -
$3.23
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.27
Resistance Level
$5.20
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.46
Wall Street Target
$12.00
(+199.3%)
Revenue Growth (YoY)
47.6%
Valuation Discount vs History
-7.5% cheaper
PE vs Historical
11.5 vs 14.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.5%
(market-implied from PE analysis)
1-Year Target
$3.71
(-8%)
2-Year Target
$3.43
(-14%)
3-Year Target
$3.17
(-21%)
3-Yr Target (if PE normalizes)
(PE: 11→15)
$4.02
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.5 to 14.5
Stabilization Target:
$5.07
(+26.6%)
PE Expansion Potential:
+26.6%
Share & Embed Analysis
Last updated: May 15, 2026 9:28 PM ET
Data refreshes hourly during market hours. Next update: 10:28 PM
Data refreshes hourly during market hours. Next update: 10:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 58 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |